These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 35475329)

  • 1. Hyperandrogenism and Polycystic ovary syndrome: Effects in pregnancy and offspring development.
    Abruzzese GA; Silva AF; Velazquez ME; Ferrer MJ; Motta AB
    WIREs Mech Dis; 2022 Sep; 14(5):e1558. PubMed ID: 35475329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy complications in women with polycystic ovary syndrome.
    Palomba S; de Wilde MA; Falbo A; Koster MP; La Sala GB; Fauser BC
    Hum Reprod Update; 2015; 21(5):575-92. PubMed ID: 26117684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS).
    Siddiqui S; Mateen S; Ahmad R; Moin S
    J Assist Reprod Genet; 2022 Nov; 39(11):2439-2473. PubMed ID: 36190593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-morbidity of cervical incompetence with polycystic ovarian syndrome (PCOS) negatively impacts prognosis: A retrospective analysis of 178 patients.
    Wang Y; Gu X; Tao L; Zhao Y
    BMC Pregnancy Childbirth; 2016 Oct; 16(1):308. PubMed ID: 27733131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective cohort study of obstetric complications and birth outcomes in women with polycystic ovarian syndrome.
    Liu Q; Wang J; Xu Q; Kong L; Wang J
    J Obstet Gynaecol; 2022 May; 42(4):574-579. PubMed ID: 34392796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of polycystic ovary syndrome without hyperandrogenism on pregnancy-related outcomes: a retrospective cohort study.
    Hu S; Xu B; Long R; Jin L
    BJOG; 2021 May; 128(6):1003-1010. PubMed ID: 33021046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between maternal polycystic ovarian syndrome undergoing assisted reproductive technology and pregnancy complications and neonatal outcomes: a systematic review and meta-analysis.
    Ban M; Sun Y; Chen X; Zhou X; Zhang Y; Cui L
    J Ovarian Res; 2024 Jan; 17(1):6. PubMed ID: 38184624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of maternal polycystic ovary syndrome and diabetes with preterm birth and offspring birth size: a population-based cohort study.
    Chen X; Gissler M; Lavebratt C
    Hum Reprod; 2022 May; 37(6):1311-1323. PubMed ID: 35348682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal serum levels of prokineticin-1 related to pregnancy complications and metformin use in women with polycystic ovary syndrome: a post hoc analysis of two prospective, randomised, placebo-controlled trials.
    Ujvari D; Trouva A; Hirschberg AL; Vanky E
    BMJ Open; 2023 Nov; 13(11):e073619. PubMed ID: 37989369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preconception health optimization in women with polycystic ovary syndrome - how to find the time?
    Lennon C; Voss K; Vitek WS
    Curr Opin Endocrinol Diabetes Obes; 2022 Dec; 29(6):541-546. PubMed ID: 36218230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycystic ovary syndrome and risk of adverse obstetric outcomes: a retrospective population-based matched cohort study in England.
    Subramanian A; Lee SI; Phillips K; Toulis KA; Kempegowda P; O'Reilly MW; Adderley NJ; Thangaratinam S; Arlt W; Nirantharakumar K
    BMC Med; 2022 Aug; 20(1):298. PubMed ID: 36038914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-Conception Characteristics Predict Obstetrical and Neonatal Outcomes in Women With Polycystic Ovary Syndrome.
    Christ JP; Gunning MN; Meun C; Eijkemans MJC; van Rijn BB; Bonsel GJ; Laven JSE; Fauser BCJM
    J Clin Endocrinol Metab; 2019 Mar; 104(3):809-818. PubMed ID: 30590587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy outcomes and the effect of metformin treatment in women with polycystic ovary syndrome: an overview.
    Ghazeeri GS; Nassar AH; Younes Z; Awwad JT
    Acta Obstet Gynecol Scand; 2012 Jun; 91(6):658-78. PubMed ID: 22375613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of hyperandrogenism on obstetric complications of singleton pregnancy from in vitro fertilization in women with polycystic ovary syndrome].
    Wei DM; Zhang ZZ; Wang Z; Li P; Wang JF; Liu YJ; Zhang JT; Shi YH
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jan; 53(1):18-22. PubMed ID: 29374881
    [No Abstract]   [Full Text] [Related]  

  • 16. Hyperandrogenism and phenotypes of polycystic ovary syndrome are not associated with differences in obstetric outcomes.
    Mumm H; Jensen DM; Sørensen JA; Andersen LL; Ravn P; Andersen M; Glintborg D
    Acta Obstet Gynecol Scand; 2015 Feb; 94(2):204-11. PubMed ID: 25417943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In utero exposure to maternal stressful life events and risk of polycystic ovary syndrome in the offspring: The Raine Study.
    Koch T; Doherty DA; Dickinson JE; Juul A; Hart R; Bräuner EV; Hickey M
    Psychoneuroendocrinology; 2021 Mar; 125():105104. PubMed ID: 33352473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polycystic Ovarian Syndrome (PCOS): Does the Challenge End at Conception?
    Mirza FG; Tahlak MA; Rjeili RB; Hazari K; Ennab F; Hodgman C; Khamis AH; Atiomo W
    Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of exposure to second-hand smoke from husbands on biochemical hyperandrogenism, metabolic syndrome and conception rates in women with polycystic ovary syndrome undergoing ovulation induction.
    Li J; Wu Q; Wu XK; Zhou ZM; Fu P; Chen XH; Yan Y; Wang X; Yang ZW; Li WL; Stener-Victorin E; Legro RS; Ng EH; Zhang H; Mol BWJ; Wang CC;
    Hum Reprod; 2018 Apr; 33(4):617-625. PubMed ID: 29471520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obstetric and neonatal outcome of ART in patients with polycystic ovary syndrome: IVM of oocytes versus controlled ovarian stimulation.
    Mostinckx L; Segers I; Belva F; Buyl R; Santos-Ribeiro S; Blockeel C; Smitz J; Anckaert E; Tournaye H; De Vos M
    Hum Reprod; 2019 Aug; 34(8):1595-1607. PubMed ID: 31347678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.